Allergy

News Allergy

• Allergic disease worsens respiratory symptoms and exacerbations in COPD

  Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore. "Although allergic sensitization and more

• Anergis obtains U.S. patent for AllerT

  Anergis has been granted patent protection for its AllerT birch pollen allergy treatment in the U.S. The patent No. 8,343,503 granted by the U.S. Patent Office broadly covers composition of matter and medical use of AllerT, the lead product of Anergis. AllerT is composed of a set of three contiguous more

• BASF dedicates global dermatology lab
  

  BASF announced the opening of a new global dermatology laboratory at 500 White Plains Road in Tarrytown NY. The lab will focus on topical formulations for the pharmaceutical market. Work will include basic research on skin irritation and allergy reactions to full formulations using BASF solubilizers more

White papers Allergy

• Membrane Fluidity Measurements Using UV Fluorescence Polarization and the POLARstar Omega
  

  The POLARstar Omega microplate reader from BMG LABTECH was used to study membrane fluidity via fluorescence polarization in 96-well format. The method allows for the monitoring of large scale alterations in membrane fluidity (such as phase transitions), as well as more subtle changes in lipid dynamic. The change in polarization caused by dibucaine and propranolol were investigated in both liposomes and mitochondrial membranes more

Publications Allergy

• The site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerism

  The transplantation of allergens (e.g. Phl p 5 or Bet v 1) expressed on bone marrow cells as membrane‐anchored full‐length proteins leads to permanent tolerance at the T‐cell, B‐cell and effector‐cell levels. Since the exposure of complete allergens bears the risk of inducing anaphylaxis, we inves more

• Recent advances in the diagnosis and therapy of peanut allergy

  Peanut allergy is a life-threatening, IgE-mediated allergic disease. In developed countries, the prevalence rate of peanut allergy in school-aged children is reported to be in excess of 1% and continues to rise, representing a major public health concern. Peanut allergy is diagnosed on the basis of more

• Improving patient tolerability in immunoglobulin treatment: focus on stabilizer effects

  Various types of excipients are added to immunoglobulin preparations to stabilize the product and prevent aggregation and dimer formation. These excipients, which are also called stabilizers or additives, are not inert chemicals and may have clinical implications. This is one reason why immunoglobul more

Market studies Allergy

• Grass Pollen Allergy – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Grass Pollen Allergy - Pipeline Review, H1 2012', provides an overview of the Grass Pollen Allergy therapeutic pipeline. This report provides information on the therapeutic development for Grass Pollen Allergy, complete with latest updates, and special featur more

• Birch Pollen Allergy – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Birch Pollen Allergy - Pipeline Review, H1 2012', provides an overview of the Birch Pollen Allergy therapeutic pipeline. This report provides information on the therapeutic development for Birch Pollen Allergy, complete with latest updates, and special featur more

• House Dust Mite Allergy – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'House Dust Mite Allergy - Pipeline Review, H1 2012', provides an overview of the House Dust Mite Allergy therapeutic pipeline. This report provides information on the therapeutic development for House Dust Mite Allergy, complete with latest updates, and speci more

Websites Allergy